The European Medicines Agency (EMA) has released a new reflection paper discussing how products are classified as advanced therapy medicinal products (ATMPs). In the EU, medicinal products derived ...
Pain, depression, asthenia, and insomnia: Prevalence of this symptoms cluster and its impact on health-related quality of life in a cohort of advanced cancers No significant financial relationships to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results